Eton Pharmaceuticals (ETON) Capital Expenditures (2018 - 2025)
Eton Pharmaceuticals (ETON) reported Capital Expenditures of $49000.0 for Q4 2025, up 308.33% on a YoY basis from $12000.0 in Q4 2024, and down 82.75% sequentially from $284000.0 in Q3 2025.
Eton Pharmaceuticals (ETON) Capital Expenditures (2018 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of Capital Expenditures data on file, last reported at $49000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures rose 308.33% year-over-year to $49000.0; the trailing twelve-month figure through Dec 2025 stood at $333000.0 (up 1180.77% YoY), and the FY2025 full-year result was $333000.0, up 1180.77% from the prior year.
- Capital Expenditures declined to $49000.0 in Q4 2025, from $284000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $284000.0 in Q3 2025 to a low of $2000.0 in Q3 2021.
- A 4-year average of $44777.8 and a median of $12000.0 in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures sank 90.91% in 2021 and jumped 308.33% in 2025, its largest moves.
- Tracing ETON's Capital Expenditures over 4 years: stood at $4000.0 in 2021, then surged by 200.0% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2024, then soared by 308.33% to $49000.0 in 2025.
- Business Quant data shows ETON's Capital Expenditures at $49000.0 in Q4 2025, $284000.0 in Q3 2025, and $12000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 49,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49,000.00 |
| Dec 31, 2025 | 49,000.00 |
| Sep 30, 2025 | 284,000.00 |
| Sep 30, 2025 | 284,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Dec 31, 2020 | 44,000.00 |
| Dec 31, 2020 | 44,000.00 |